Those Requiring Repeat Peptide Receptor Radionuclide Therapy
1 clinical trials · Condition
◉ Watch Those Requiring Repeat Peptide Receptor Radionuclide Therapy
| Record | Firm | Date |
|---|---|---|
| Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications (NCT06121271) | University College, London | 2023-12-18 |
Track Those Requiring Repeat Peptide Receptor Radionuclide Therapy automatically
Every clearance here is in the API, with alerts when new ones post.